MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-196.01M
↓ 163% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-74.46M
Historical baseline
PeriodValueYoY Change
2025$-196.01M-68.1%
2024$-116.59M-172.5%
2023$-42.78M+23.5%
2022$-55.89M-58.9%
2021$-35.18M-11007.1%
2020$-316692.00-